Jonathan H Chung1, Xi Zhan2, Mengshu Cao3, Tilman L Koelsch4, Diana C Gomez Manjarres5, Kevin K Brown6, David A Lynch4, Gloria Russell7, Evans R Fernández Pérez6. 1. 1 Division of Thoracic Radiology, University of Chicago, Chicago, Illinois. 2. 2 Division of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China. 3. 3 Division of Pulmonary and Critical Care Medicine, Beijing Chaoyang Hospital, Beijing, China. 4. 4 Division of Thoracic Radiology, National Jewish Health, Denver, Colorado. 5. 5 Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia. 6. 6 Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado; and. 7. 7 Pontificia Universidad Católica Madre y Maestra, Santiago, Dominican Republic.
Abstract
RATIONALE: Significant heterogeneity of computed tomography (CT) presentation exists within chronic hypersensitivity pneumonitis (HP). There are limited data aimed at delineating the prognostic value of specific CT features, distribution, and patterns in chronic HP. OBJECTIVES: To examine whether the presence of CT mosaic attenuation (MA) and air trapping (AT), and the distribution or patterns of fibrosis impact survival in subjects with chronic HP. METHODS: We retrospectively identified 110 consecutively enrolled, well-characterized, biopsy-proven adult subjects with chronic HP between 1982 and 2015 from the National Jewish Health interstitial lung disease research database. The first available CT scan of diagnostic quality from each subject was formally evaluated for specific CT findings associated with chronic HP and for overall CT pattern. A Cox proportional hazards model was used to identify independent predictors in time-to-death analysis, and bootstrap analysis was performed for internal model validation. RESULTS: Fibrotic HP (65%; 72/110) was most often peripheral in the axial plane and lower lung preponderant. The distribution of lung disease in those without fibrosis was most often axially and zonally diffuse. There was no association between survival and CT distribution or CT pattern in the whole cohort or within the fibrotic subset of subjects. After multivariate adjustment, AT/MA was independently associated with survival in the whole cohort (HR = 0.26; 95% confidence interval = 0.07-0.97). Results were similar after restricting the analyses to fibrotic HP cases. CONCLUSIONS: Among subjects with chronic HP, the presence of CT AT/MA may identify subjects with better prognosis.
RATIONALE: Significant heterogeneity of computed tomography (CT) presentation exists within chronic hypersensitivitypneumonitis (HP). There are limited data aimed at delineating the prognostic value of specific CT features, distribution, and patterns in chronic HP. OBJECTIVES: To examine whether the presence of CT mosaic attenuation (MA) and air trapping (AT), and the distribution or patterns of fibrosis impact survival in subjects with chronic HP. METHODS: We retrospectively identified 110 consecutively enrolled, well-characterized, biopsy-proven adult subjects with chronic HP between 1982 and 2015 from the National Jewish Health interstitial lung disease research database. The first available CT scan of diagnostic quality from each subject was formally evaluated for specific CT findings associated with chronic HP and for overall CT pattern. A Cox proportional hazards model was used to identify independent predictors in time-to-death analysis, and bootstrap analysis was performed for internal model validation. RESULTS:Fibrotic HP (65%; 72/110) was most often peripheral in the axial plane and lower lung preponderant. The distribution of lung disease in those without fibrosis was most often axially and zonally diffuse. There was no association between survival and CT distribution or CT pattern in the whole cohort or within the fibrotic subset of subjects. After multivariate adjustment, AT/MA was independently associated with survival in the whole cohort (HR = 0.26; 95% confidence interval = 0.07-0.97). Results were similar after restricting the analyses to fibrotic HP cases. CONCLUSIONS: Among subjects with chronic HP, the presence of CT AT/MA may identify subjects with better prognosis.
Authors: Ayodeji Adegunsoye; Justin M Oldham; Catherine Bonham; Cara Hrusch; Paul Nolan; Wesley Klejch; Shashi Bellam; Uday Mehta; Kiran Thakrar; Janelle Vu Pugashetti; Aliya N Husain; Steven M Montner; Christopher M Straus; Rekha Vij; Anne I Sperling; Imre Noth; Mary E Strek; Jonathan H Chung Journal: Am J Respir Crit Care Med Date: 2019-03-15 Impact factor: 21.405
Authors: Julie Morisset; Kerri A Johannson; Kirk D Jones; Paul J Wolters; Harold R Collard; Simon L F Walsh; Brett Ley Journal: Am J Respir Crit Care Med Date: 2017-11-27 Impact factor: 21.405
Authors: Margaret L Salisbury; Tian Gu; Susan Murray; Barry H Gross; Aamer Chughtai; Mohamed Sayyouh; Ella A Kazerooni; Jeffrey L Myers; Amir Lagstein; Kristine E Konopka; Elizabeth A Belloli; Jamie S Sheth; Eric S White; Colin Holtze; Fernando J Martinez; Kevin R Flaherty Journal: Chest Date: 2018-09-19 Impact factor: 9.410
Authors: Evans R Fernández Pérez; James L Crooks; Jeffrey J Swigris; Joshua J Solomon; Michael P Mohning; Tristan J Huie; Matthew Koslow; David A Lynch; Steve D Groshong; Kaitlin Fier Journal: ERJ Open Res Date: 2021-06-07
Authors: Ayodeji Adegunsoye; Justin M Oldham; Shashi K Bellam; Steven Montner; Matthew M Churpek; Imre Noth; Rekha Vij; Mary E Strek; Jonathan H Chung Journal: Ann Am Thorac Soc Date: 2019-05
Authors: Evans R Fernández Pérez; Laura D Harmacek; Brian P O'Connor; Thomas Danhorn; Brian Vestal; Lisa A Maier; Tilman L Koelsch; Sonia M Leach Journal: Thorax Date: 2021-06-28 Impact factor: 9.102